Advances in Nanoparticle-Mediated Drug Delivery
A special issue of Scientia Pharmaceutica (ISSN 2218-0532).
Deadline for manuscript submissions: closed (30 November 2019) | Viewed by 5811
Special Issue Editors
Interests: cancer therapy; drug delivery; drug targeting; infectious disease; micelle; nanoparticles; nanotechnology; polymers; targeted therapies; HIV; antibody engineering; antibody–drug conjugates
Special Issues, Collections and Topics in MDPI journals
Interests: magnetic nanoparticles; cancer medicine; drug targeting; nanotechnology; polymers; targeted therapies
Special Issues, Collections and Topics in MDPI journals
Interests: biopolymers; nanomedicine; drug delivery; hydrogels for advanced biomedical applications
Special Issues, Collections and Topics in MDPI journals
Special Issue Information
Dear Colleagues,
Developments in fundamental knowledge and engineering sciences have helped the field of pharmaceutics. Nanotechnology-based materials are emerging as drug delivery carriers. This Special Issue entitled “Advances in Nanoparticle-Mediated Drug Delivery” from Scientia Pharmaceutica calls for cutting-edge research and review manuscripts dealing with insights of current developments of nanoparticles for targeted drug delivery. The issue will be focused on molecular drug targets, including disease-specific proteins, receptors, enzymes, and genes, which seek to elucidate the impact of new therapeutic agents on patient acceptability, preference, satisfaction, and quality of life.
Dr. Murali Mohan Yallapu
Dr. Raghvendra A. Bohara
Dr. Varaprasad Kokkarachedu
Guest Editors
Manuscript Submission Information
Manuscripts should be submitted online at www.mdpi.com by registering and logging in to this website. Once you are registered, click here to go to the submission form. Manuscripts can be submitted until the deadline. All submissions that pass pre-check are peer-reviewed. Accepted papers will be published continuously in the journal (as soon as accepted) and will be listed together on the special issue website. Research articles, review articles as well as short communications are invited. For planned papers, a title and short abstract (about 100 words) can be sent to the Editorial Office for announcement on this website.
Submitted manuscripts should not have been published previously, nor be under consideration for publication elsewhere (except conference proceedings papers). All manuscripts are thoroughly refereed through a single-blind peer-review process. A guide for authors and other relevant information for submission of manuscripts is available on the Instructions for Authors page. Scientia Pharmaceutica is an international peer-reviewed open access quarterly journal published by MDPI.
Please visit the Instructions for Authors page before submitting a manuscript. The Article Processing Charge (APC) for publication in this open access journal is 1000 CHF (Swiss Francs). Submitted papers should be well formatted and use good English. Authors may use MDPI's English editing service prior to publication or during author revisions.
Keywords
- targeted drug delivery
- nanoparticles
- cancer nanomedicine
- antibiotics
- polymers
Benefits of Publishing in a Special Issue
- Ease of navigation: Grouping papers by topic helps scholars navigate broad scope journals more efficiently.
- Greater discoverability: Special Issues support the reach and impact of scientific research. Articles in Special Issues are more discoverable and cited more frequently.
- Expansion of research network: Special Issues facilitate connections among authors, fostering scientific collaborations.
- External promotion: Articles in Special Issues are often promoted through the journal's social media, increasing their visibility.
- e-Book format: Special Issues with more than 10 articles can be published as dedicated e-books, ensuring wide and rapid dissemination.
Further information on MDPI's Special Issue polices can be found here.
